IP Library Granted Patent US 8,060,197
Granted Patent B2
US 8,060,197 · App. 11/724,899 · Granted Nov 15, 2011

Parasympathetic stimulation for termination of non-sinus atrial tachycardia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,060,197
App. No.
11/724,899
Granted
Nov 15, 2011
Kind
B2
Abstract

Apparatus is provided, which includes an electrode device, configured to be coupled to an atrial site of a subject containing parasympathetic nervous tissue, and a control unit. The control unit is configured to, responsively to a detection of an episode of non-sinus atrial tachycardia, restore normal sinus rhythm (NSR) of the subject, by driving the electrode device to apply a parasympathetic stimulation signal to the atrial site, and configuring the parasympathetic stimulation signal to activate the parasympathetic nervous tissue sufficiently to restore the NSR. Other embodiments are also described.

Claims (73)

1. Apparatus comprising:

a monitor, configured to sense one or more physiological parameters;

an electrode device, configured to be coupled to a baroreceptor site of a subject; and

a control unit, configured to detect an episode of non-sinus atrial tachycardia responsively to the one or more sensed physiological parameters, and, responsively to the detection, restore normal sinus rhythm (NSR) of the subject, by:

driving the electrode device to apply a stimulation signal to the baroreceptor site, and

configuring the stimulation signal to lower a blood pressure of the subject sufficiently to restore the NSR.

2. The apparatus according to claim 1 , wherein the non-sinus atrial tachycardia includes atrial fibrillation (AF), and wherein the control unit is configured to restore the NSR responsively to the detection of the episode of the AF.

3. The apparatus according to claim 1 , wherein the non-sinus atrial tachycardia includes atrial flutter, and wherein the control unit is configured to restore the NSR responsively to the detection of the episode of the atrial flutter.

4. The apparatus according to claim 1 , wherein the electrode device comprises an intravascular electrode lead.

5. The apparatus according to claim 1 , wherein the control unit is configured to apply the stimulation signal at between 50 and 200 pulses per second.

6. The apparatus according to claim 1 , wherein the control unit is configured to restore the NSR by:

driving the electrode device to apply the stimulation signal at a first strength during a first stimulation session,

determining whether the episode has been successfully resolved responsively to the one or more sensed physiological parameters, and

responsively to a determination that the episode has not been resolved, driving the electrode device to apply the stimulation signal at a second strength during a second stimulation session subsequent to the first stimulation session, wherein the second strength is greater than the first strength.

7. The apparatus according to claim 1 , wherein the control unit is configured to apply a cardiac muscle signal to at least one atrium of the subject selected from the group consisting of: an atrium including the atrial site, and an atrium contralateral to the atrium including the atrial site, and to configure the cardiac muscle signal to stimulate cardiac muscle tissue.

8. The apparatus according to claim 7 , wherein the at least one atrium includes the atrium including the atrial site, and wherein the control unit is configured to drive the electrode device to apply the cardiac muscle signal to the atrial site.

9. The apparatus according to claim 1 , wherein the control unit is configured to apply the stimulation signal during a ventricular refractory period of the cardiac cycle.

10. The apparatus according to claim 1 , wherein the control unit is configured to begin to apply the stimulation signal after a delay after the detection, if the episode has not been resolved during the delay.

11. The apparatus according to claim 1 , further comprising a blood pressure sensor configured to generate a blood pressure signal, wherein the control unit is configured to lower the blood pressure to a target level responsively to the blood pressure signal.

12. The apparatus according to claim 1 , wherein the baroreceptor site is selected from the group consisting of: a carotid bifurcation, and a jugular vein, and wherein the electrode device is configured to be coupled to the selected site.

13. Apparatus comprising:

a monitor, configured to sense one or more physiological parameters;

an electrode device, configured to be coupled to a baroreceptor site of a subject; and

a control unit, configured to:

detect an episode of non-sinus atrial tachycardia responsively to the one or more sensed physiological parameters,

responsively to the detection, wait during a delay period,

upon conclusion of the delay period, determine whether the episode has been successfully resolved responsively to the one or more sensed physiological parameters, and

responsively to a determination that the episode has not been resolved, restore normal sinus rhythm (NSR) of the subject by:

driving the electrode device to apply a stimulation signal to the baroreceptor site, and

configuring the stimulation signal to lower a blood pressure of the subject sufficiently to restore the NSR.

14. The apparatus according to claim 13 , wherein the delay period has a duration of at least ten seconds.

15. The apparatus according to claim 13 , wherein the non-sinus atrial tachycardia includes atrial fibrillation (AF), and wherein the control unit is configured to restore the NSR responsively to the detection of the episode of the AF.

16. The apparatus according to claim 13 , wherein the non-sinus atrial tachycardia includes atrial flutter, and wherein the control unit is configured to restore the NSR responsively to the detection of the episode of the atrial flutter.

17. The apparatus according to claim 13 , further comprising a blood pressure sensor configured to generate a blood pressure signal, wherein the control unit is configured to lower the blood pressure to a target level responsively to the blood pressure signal.

18. The apparatus according to claim 13 , wherein the baroreceptor site is selected from the group consisting of: a carotid bifurcation, and a jugular vein, and wherein the electrode device is configured to be coupled to the selected site.

19. A method comprising:

detecting an episode of non-sinus atrial tachycardia of a subject; and

responsively to the detecting, restoring normal sinus rhythm (NSR) of the subject, by:

applying a stimulation signal to a baroreceptor site of the subject, and

configuring the stimulation signal to lower a blood pressure of the subject sufficiently to restore the NSR.

20. The method according to claim 19 , wherein the non-sinus atrial tachycardia includes atrial fibrillation (AF), and wherein detecting the episode comprises detecting the episode of the AF.

21. The method according to claim 19 , wherein the non-sinus atrial tachycardia includes atrial flutter, and wherein detecting the episode comprises detecting the episode of the atrial flutter.

22. The method according to claim 19 , wherein applying the stimulation signal comprises applying the stimulation signal from an intravascular site.

23. The method according to claim 19 , wherein configuring the stimulation signal comprises applying the stimulation signal at between 50 and 200 pulses per second.

24. The method according to claim 19 , wherein restoring the NSR comprises restoring the NSR by:

applying the stimulation signal at a first strength during a first stimulation session, and

responsively to a determination that the episode has not been resolved, applying the stimulation signal at a second strength during a second stimulation session subsequent to the first stimulation session, wherein the second strength is greater than the first strength.

25. The method according to claim 19 , comprising applying a cardiac muscle signal to at least one atrium of the subject selected from the group consisting of: an atrium including the atrial site, and an atrium contralateral to the atrium including the atrial site, and configuring the cardiac muscle signal to stimulate cardiac muscle tissue.

26. The method according to claim 25 , wherein the at least one atrium includes the atrium including the atrial site, and wherein applying the cardiac muscle signal comprises applying the cardiac muscle signal to the atrial site.

27. The method according to claim 19 , wherein applying the stimulation signal comprises applying the stimulation signal during a ventricular refractory period of the cardiac cycle.

28. The method according to claim 19 , wherein applying the stimulation signal comprises beginning to apply the stimulation signal after a delay after the detecting, if the episode has not been resolved during the delay.

29. The method according to claim 19 , wherein configuring the stimulation signal comprises setting, during a calibration procedure, at least one parameter of the stimulation signal to have a minimum value sufficient to achieve a desired effect.

30. The method according to claim 29 , wherein the desired effect includes a reduction in systolic blood pressure of the subject.

31. The method according to claim 19 , wherein configuring the stimulation signal comprises determining, during a calibration procedure, a maximum value of at least one parameter of the stimulation signal that is safe for the subject.

32. The method according to claim 31 , wherein determining the maximum value comprises determining the maximum value that does not reduce systolic blood pressure below a threshold value.

33. The method according to claim 19 , comprising performing, prior to detecting the episode, an acute test to determine whether the subject is expected to benefit from the applying the stimulation signal.

34. The method according to claim 19 , wherein restoring the NSR comprises:

sensing the blood pressure; and

lowering the blood pressure to a target level responsively to the sensed blood pressure.

35. The method according to claim 19 , wherein the site is selected from the group consisting of: a carotid bifurcation, and a jugular vein, and applying the electrical signal comprises applying the electrical signal to the selected site.

36. A method comprising:

detecting an episode of non-sinus atrial tachycardia of a subject;

responsively to the detecting, waiting during a delay period; and

upon conclusion of the delay period, responsively to a determination that the episode has not been resolved, restoring normal sinus rhythm (NSR) of the subject by:

applying a stimulation signal to a baroreceptor site of a subject, and

configuring the stimulation signal to lower a blood pressure of the subject sufficiently to restore the NSR.

37. The method according to claim 36 , wherein the delay period has a duration of at least ten seconds.

38. The method according to claim 36 , wherein the non-sinus atrial tachycardia includes atrial fibrillation (AF), and wherein detecting the episode comprises detecting the episode of the AF.

39. The method according to claim 36 , wherein the non-sinus atrial tachycardia includes atrial flutter, and wherein detecting the episode comprises detecting the episode of the atrial flutter.

40. The method according to claim 36 , wherein restoring the NSR comprises:

sensing the blood pressure; and

lowering the blood pressure to a target level responsively to the sensed blood pressure.

41. The method according to claim 36 , wherein the site is selected from the group consisting of: a carotid bifurcation, and a jugular vein, and applying the electrical signal comprises applying the electrical signal to the selected site.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2018
From: BIOCONTROL ,EDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 046574/0208 →
SECURITY AGREEMENT Recorded May 20, 2010
From: BIO CONTROL MEDICAL (B.C.M.) LTD
To: MEDTRONIC, INC.
Reel/Frame 024411/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: BIOCONTROL MEDICAL, LTD.
To: BIO CONTROL MEDICAL (B.C.M.) LTD.
Reel/Frame 020783/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2007
From: BEN-DAVID, TAMIR; BEN-EZRA, OMRY; COHEN, EHUD
To: BIOCONTROL MEDICAL LTD.
Reel/Frame 019307/0439 →